OBI-822/821 Phase II/III Study Does Not Meet PFS Endpoint, But Shows Positive Results in Breast Cancer Patients with Immune Response February 29, 2016Vol.39 No.02
Drugs & Targets FDA Approves Gazyva Plus Bendamustine for Patients with Follicular Lymphoma February 29, 2016Vol.39 No.02
Halaven Study Improves Overall Survival In Liposarcomas and Leiomyosarcomas February 29, 2016Vol.39 No.02
Phase III Blincyto Study in Leukemia Stopped Early After Meeting OS Primary Endpoint February 29, 2016Vol.39 No.02
In Brief Indiana University Simon Cancer Center receives grant from Kay Yow Cancer Fund February 26, 2016Vol.42 No.08
Drugs & Targets FDA grants Breakthrough Designation to PKC412 (midostaurin) February 26, 2016Vol.42 No.08
Drugs & Targets FDA approves Afinitor for GI or lung neuroendocrine tumors February 26, 2016Vol.42 No.08
In Brief Bharat Aggarwal has seven papers retracted from Biochemical Pharmacology February 26, 2016Vol.42 No.08
In Brief Robert Korngold receives lifetime achievement award from the American Society for Blood and Marrow Transplantation February 26, 2016Vol.42 No.08
